Atle-Fund-Management-Ab

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ALKS",
  "KRYS",
  "NAMS",
  "RVMD",
  "ABBV",
  "BSX",
  "MREO",
  "BCAX",
  "MIRM",
  "SMMT",
  "GILD",
  "JANX",
  "AUTL",
  "ISRG",
  "NBIX",
  "UNH",
  "MRK",
  "AMGN",
  "SYK",
  "TMO",
  "UFPT",
  "SLNO",
  "ACLX",
  "VRTX",
  null,
  "EW",
  "CAH",
  "HRMY",
  "VRNA",
  "IRTC",
  null,
  "BBIO",
  "CABA",
  "CRBP",
  "DXCM",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-05
Total Holdings: 37
Total Value: 226505046
Accession Number: 0001381843-25-000004
Form Type: 13F-HR
CIK: atle-fund-management-ab
Manager Name: Atle-Fund-Management-Ab

Data Enrichment

95% identified

35 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

37 positions • $226.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

Mirum Pharmaceuticals, Inc.

MIRM|604749101

Shares:77.3K

Value:$3.5M

% of Portfolio:1.5% ($3.5M/$226.5M)

DEXCOM INC

DXCM|252131107

Shares:45.8K

Value:$3.1M

% of Portfolio:1.4% ($3.1M/$226.5M)

Harmony Biosciences Holdings, Inc.

HRMY|413197104

Shares:91.3K

Value:$3.0M

% of Portfolio:1.3% ($3.0M/$226.5M)

Arcellx, Inc.

ACLX|03940C100

Shares:44.2K

Value:$2.9M

% of Portfolio:1.3% ($2.9M/$226.5M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:37.1K

Value:$2.7M

% of Portfolio:1.2% ($2.7M/$226.5M)

NewAmsterdam Pharma Co N.V.

NAMS|N62509109

Shares:107.8K

Value:$2.2M

% of Portfolio:1.0% ($2.2M/$226.5M)

Verona Pharma plc

VRNA|925050106

Shares:34.7K

Value:$2.2M

% of Portfolio:1.0% ($2.2M/$226.5M)

iRhythm Technologies, Inc.

IRTC|450056106

Shares:20.5K

Value:$2.2M

% of Portfolio:0.9% ($2.2M/$226.5M)

Summit Therapeutics Inc.

SMMT|86627T108

Shares:105.1K

Value:$2.0M

% of Portfolio:0.9% ($2.0M/$226.5M)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:55.0K

Value:$1.9M

% of Portfolio:0.9% ($1.9M/$226.5M)

Bicara Therapeutics Inc.

BCAX|055477103

Shares:119.8K

Value:$1.6M

% of Portfolio:0.7% ($1.6M/$226.5M)

Merus N.V.

MRUS|N5749R100

Shares:35.3K

Value:$1.5M

% of Portfolio:0.7% ($1.5M/$226.5M)

Janux Therapeutics, Inc.

JANX|47103J105

Shares:46.8K

Value:$1.3M

% of Portfolio:0.6% ($1.3M/$226.5M)

Mereo BioPharma Group plc

MREO|589492107

Shares:390.0K

Value:$877.5K

% of Portfolio:0.4% ($877.5K/$226.5M)

Autolus Therapeutics plc

AUTL|05280R100

Shares:479.6K

Value:$743.4K

% of Portfolio:0.3% ($743.4K/$226.5M)

Corbus Pharmaceuticals Holdings, Inc.

CRBP|21833P301

Shares:98.3K

Value:$522.0K

% of Portfolio:0.2% ($522.0K/$226.5M)

Cabaletta Bio, Inc.

CABA|12674W109

Shares:182.4K

Value:$252.6K

% of Portfolio:0.1% ($252.6K/$226.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	77.3K	QoQ -33.78% (-39.4K) YoY -37.18% (-45.7K)	All Managers (Combined)	$3.5M	1.5% ($3.5M/$226.5M)	QoQ -27.56% (-$1.3M) YoY +12.65% (-$390.9K)
DEXCOM INC(DXCMcusip252131107)	45.8K	QoQ -23.67% (-14.2K) YoY +74.41% (-19.6K)	All Managers (Combined)	$3.1M	1.4% ($3.1M/$226.5M)	QoQ -33.17% (-$1.6M) YoY -14.12% (-$515.0K)
Harmony Biosciences Holdings, Inc.(HRMYcusip413197104)	91.3K	QoQ -24.23% (-29.2K) YoY -46.29% (-78.7K)	All Managers (Combined)	$3.0M	1.3% ($3.0M/$226.5M)	QoQ -26.16% (-$1.1M) YoY -46.91% (-$2.7M)
Arcellx, Inc.(ACLXcusip03940C100)	44.2K	QoQ +4.99% (-2.1K) YoY +152.46% (+26.7K)	All Managers (Combined)	$2.9M	1.3% ($2.9M/$226.5M)	QoQ -12.09% (-$398.6K) YoY +138.12% (+$1.7M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	37.1K	QoQ +19.90% (+6.2K) YoY NEW(+37.1K)	All Managers (Combined)	$2.7M	1.2% ($2.7M/$226.5M)	QoQ +169.15% (+$1.7M) YoY NEW(+$2.7M)
NewAmsterdam Pharma Co N.V.(NAMScusipN62509109)	107.8K	QoQ -22.44% (-31.2K) YoY +381.30% (+85.4K)	All Managers (Combined)	$2.2M	1.0% ($2.2M/$226.5M)	QoQ -37.98% (-$1.4M) YoY +316.58% (+$1.7M)
Verona Pharma plc(VRNAcusip925050106)	34.7K	QoQ NEW(+34.7K) YoY NEW(+34.7K)	All Managers (Combined)	$2.2M	1.0% ($2.2M/$226.5M)	QoQ NEW(+$2.2M) YoY NEW(+$2.2M)
iRhythm Technologies, Inc.(IRTCcusip450056106)	20.5K	QoQ NEW(+20.5K) YoY NEW(+20.5K)	All Managers (Combined)	$2.2M	0.9% ($2.2M/$226.5M)	QoQ NEW(+$2.2M) YoY NEW(+$2.2M)
Summit Therapeutics Inc.(SMMTcusip86627T108)	105.1K	QoQ +3.85% (+3.9K) YoY NEW(+105.1K)	All Managers (Combined)	$2.0M	0.9% ($2.0M/$226.5M)	QoQ +54.17% (+$712.3K) YoY NEW(+$2.0M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	55.0K	QoQ -11.58% (-7.2K) YoY NEW(+55.0K)	All Managers (Combined)	$1.9M	0.9% ($1.9M/$226.5M)	QoQ -27.57% (-$740.1K) YoY NEW(+$1.9M)
Bicara Therapeutics Inc.(BCAXcusip055477103)	119.8K	QoQ NEW(+119.8K) YoY NEW(+119.8K)	All Managers (Combined)	$1.6M	0.7% ($1.6M/$226.5M)	QoQ NEW(+$1.6M) YoY NEW(+$1.6M)
Merus N.V.(MRUScusipN5749R100)	35.3K	QoQ -43.55% (-27.2K) YoY +45.08% (+11.0K)	All Managers (Combined)	$1.5M	0.7% ($1.5M/$226.5M)	QoQ -43.28% (-$1.1M) YoY +35.61% (+$390.1K)
Janux Therapeutics, Inc.(JANXcusip47103J105)	46.8K	QoQ +18.28% (-7.2K) YoY NEW(+46.8K)	All Managers (Combined)	$1.3M	0.6% ($1.3M/$226.5M)	QoQ -39.16% (-$813.8K) YoY NEW(+$1.3M)
Mereo BioPharma Group plc(MREOcusip589492107)	390.0K	QoQ 0.00% (-0) YoY NEW(+390.0K)	All Managers (Combined)	$877.5K	0.4% ($877.5K/$226.5M)	QoQ -36.07% (-$495.3K) YoY NEW(+$877.5K)
Autolus Therapeutics plc(AUTLcusip05280R100)	479.6K	QoQ 0.00% (-0) YoY +397.84% (+383.3K)	All Managers (Combined)	$743.4K	0.3% ($743.4K/$226.5M)	QoQ -29.86% (-$316.6K) YoY +20.94% (+$128.8K)
Corbus Pharmaceuticals Holdings, Inc.(CRBPcusip21833P301)	98.3K	QoQ 0.00% (-0) YoY +158.69% (-60.3K)	All Managers (Combined)	$522.0K	0.2% ($522.0K/$226.5M)	QoQ -56.04% (-$665.5K) YoY -64.99% (-$969.1K)
Cabaletta Bio, Inc.(CABAcusip12674W109)	182.4K	QoQ -26.30% (-65.1K) YoY +135.17% (-104.8K)	All Managers (Combined)	$252.6K	0.1% ($252.6K/$226.5M)	QoQ -54.43% (-$301.7K) YoY -80.90% (-$1.1M)